clarithromycin has been researched along with Infections, Legionella pneumophila in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 5 (23.81) | 18.2507 |
| 2000's | 9 (42.86) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Chasqueira, MJ; Cruz, C; Fernandes, F; Paixão, P; Rodrigues, L; Santos, R | 1 |
| Arnold, C; Bassetti, S; Piso, RJ | 1 |
| Akamine, M; Atsumi, E; Baba, M; Fujita, J; Furugen, M; Haranaga, S; Higa, F; Koide, M; Naha, Y; Sato, Y; Tamayose, M; Tateyama, M; Teruya, H; Uchihara, T; Yara, S | 1 |
| Arnold, F; Griffin, AT; Peyrani, P; Wiemken, T | 1 |
| Ishii, Y; Kimura, S; Sato, T; Tateda, K; Yamaguchi, K | 1 |
| Dobrick, N; Franzen, D; Müller, N | 1 |
| Andereya, S; Schneider, U; Siebert, CH; Wirtz, DC | 1 |
| Blanc, C; Gillet, M; Halkic, N; Kovacsovics, T; Ksontini, R; Meylan, P; Mosimann, F; Muheim, C; Scholl, B | 1 |
| Bando, M; Ishii, Y; Ohno, S; Sugiyama, Y | 1 |
| Mrozińska, M | 1 |
| Antonio, JM; Garau, J; Garcés, JM; Grau, S; Ribes, E; Salvadó, M | 1 |
| Carreres, A; Domingo, C; Roig, J | 1 |
| Kabe, J; Kotajima, F; Kudo, K; Sugiyama, H; Yagishita, Y; Yoshizawa, A | 1 |
| Baskerville, A; Fitzgeorge, RB; Lever, S | 1 |
| Kapell, K; Meyer, P; Segreti, J | 1 |
| Hatakeyama, S; Oka, T; Suzuki, K; Tachibana, A; Tateda, K; Yamaguchi, K | 1 |
| McWhinney, PH; Ragunathan, PL; Rowbottham, TJ | 1 |
| Huth, RG; Jahn, B; Kamin, W; Knuf, M; Meyer, HG; Trübel, HK | 1 |
| Ali, J; Bachand, R; Dawood, G; Hafeez, S; Hamedani, P; Quereshi, S; Raza, R; Yab, Z | 1 |
| Dotsu, Y; Hayashi, T; Hirota, M; Inoue, Y; Koga, H; Kohno, S; Masaki, M; Masuyama, Y; Saito, A; Yamaguchi, K | 1 |
| Bailer, R; Bower, RR; Fernandes, PB; Gade, E; Hanson, CW; Hardy, D; McDonald, E; Ramer, N; Shipkowitz, N; Swanson, R | 1 |
1 review(s) available for clarithromycin and Infections, Legionella pneumophila
| Article | Year |
|---|---|
Treatment of Legionnaires' disease. Current recommendations.
Topics: Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Tolerance; Erythromycin; Humans; Infusions, Parenteral; Legionnaires' Disease; Rifampin | 1993 |
1 trial(s) available for clarithromycin and Infections, Legionella pneumophila
| Article | Year |
|---|---|
The safety and efficacy of clarithromycin in patients with Legionella pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clarithromycin; Erythromycin; Female; Humans; Legionnaires' Disease; Male; Middle Aged | 1991 |
19 other study(ies) available for clarithromycin and Infections, Legionella pneumophila
| Article | Year |
|---|---|
Antibiotic susceptibility pattern of Portuguese environmental Legionella isolates.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Doxycycline; Fluoroquinolones; Humans; Legionella; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Portugal | 2023 |
Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Guideline Adherence; Hospitalization; Humans; Immunocompromised Host; Legionnaires' Disease; Macrolides; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Mycoplasma; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Severity of Illness Index | 2013 |
Legionella pneumonia caused by Legionella pneumophila serogroup 2: second case report in Japan.
Topics: Anti-Infective Agents; Antigens, Bacterial; Ciprofloxacin; Clarithromycin; Humans; Japan; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Serotyping; Treatment Outcome | 2008 |
Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Chi-Square Distribution; Clarithromycin; Community-Acquired Infections; Female; Humans; Kaplan-Meier Estimate; Legionella pneumophila; Legionnaires' Disease; Length of Stay; Levofloxacin; Male; Ofloxacin; Retrospective Studies; Time Factors; Treatment Outcome | 2010 |
In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bridged-Ring Compounds; Cell Line; Cells, Cultured; Clarithromycin; Disease Models, Animal; Humans; Ketolides; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Macrolides; Mice; Microbial Sensitivity Tests; Ofloxacin | 2011 |
[Legionnaires disease (legionella pneumonia)].
Topics: Aged; Anti-Bacterial Agents; Antigens, Bacterial; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Diagnosis, Differential; Humans; Legionella pneumophila; Legionnaires' Disease; Leukemia, Hairy Cell; Male; Opportunistic Infections; Patient Admission; Polymerase Chain Reaction; Prognosis; Tomography, X-Ray Computed | 2012 |
Reactive knee and ankle joint arthritis: abnormal manifestation of Legionella pneumophila.
Topics: Adult; Ankle Joint; Anti-Bacterial Agents; Arthritis, Reactive; Clarithromycin; Humans; Knee Joint; Legionella pneumophila; Legionnaires' Disease; Magnetic Resonance Imaging; Male; Radiography, Thoracic; Tomography, Spiral Computed; Treatment Outcome | 2004 |
Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report.
Topics: Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiviral Agents; Bone and Bones; Clarithromycin; Cross Infection; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Legionnaires' Disease; Leishmaniasis, Visceral; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Schistosomicides; Viral Load | 2004 |
[A travel abroad-associated case of Legionella pneumonia diagnosed by urinary antigen detection test].
Topics: Aged; Anti-Bacterial Agents; Antigens, Bacterial; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunologic Tests; Legionella pneumophila; Legionnaires' Disease; Male; Oxazines; Pneumonia, Bacterial; Travel; Turkey | 2005 |
[Legionellosis in three children--cases report].
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin M; Legionella pneumophila; Legionnaires' Disease; Male; Radiography | 2005 |
Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia.
Topics: Aged; Anti-Bacterial Agents; Bilirubin; Clarithromycin; Cohort Studies; Disease Outbreaks; Drug Therapy, Combination; Female; Humans; Legionella pneumophila; Legionnaires' Disease; Length of Stay; Male; Middle Aged; Rifampin; Spain | 2006 |
[Legionella pneumonia diagnosed by urinary antigen detection].
Topics: Antigens, Bacterial; Clarithromycin; Drug Therapy, Combination; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Methylprednisolone; Middle Aged; Rifampin | 1995 |
A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease.
Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Female; Guinea Pigs; Legionella pneumophila; Legionnaires' Disease; Lung | 1993 |
In vitro activity of macrolides against intracellular Legionella pneumophila.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Clarithromycin; Erythromycin; Humans; Legionella pneumophila; Legionnaires' Disease; Microbial Sensitivity Tests | 1996 |
[Fibrosing alveolitis following Legionella pneumonia].
Topics: Anti-Inflammatory Agents; Clarithromycin; Drug Therapy, Combination; Humans; Legionnaires' Disease; Levofloxacin; Male; Middle Aged; Minocycline; Ofloxacin; Pulmonary Fibrosis; Pulse Therapy, Drug; Steroids; Treatment Outcome | 2000 |
Failure to produce detectable antibodies to Legionella pneumophila by an immunocompetent adult.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Cefotaxime; Cephalosporins; Clarithromycin; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Erythromycin; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunocompetence; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Penicillins; Sputum; Travel; Turkey; United Kingdom | 2000 |
Complicated nosocomial pneumonia due to Legionella pneumophila in an immunocompromised child.
Topics: Anti-Bacterial Agents; Child, Preschool; Ciprofloxacin; Clarithromycin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Legionella pneumophila; Legionnaires' Disease; Male; Nutrition Disorders; Pneumonia, Bacterial | 2002 |
A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease.
Topics: Animals; Anti-Bacterial Agents; Body Fluids; Clarithromycin; Erythromycin; Guinea Pigs; Josamycin; Legionella; Legionnaires' Disease; Male; Roxithromycin; Therapeutic Irrigation | 1989 |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Drug Combinations; Drug Synergism; Erythromycin; Female; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Injections, Subcutaneous; Kinetics; Legionella; Legionnaires' Disease; Male; Mice; Microbial Sensitivity Tests; Sulfamethoxazole | 1986 |